Financials Voronoi, Inc.

Equities

A310210

KR7310210000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 23:00:00 13/06/2024 BST 5-day change 1st Jan Change
42,450 KRW -7.31% Intraday chart for Voronoi, Inc. -12.02% -21.39%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 418,266 913,616 737,646 - -
Enterprise Value (EV) 2 418.3 913.1 724.6 753.6 782.6
P/E ratio -20 x -22.5 x -19.5 x -24.2 x -22.1 x
Yield - - - - -
Capitalization / Revenue - - - 61.5 x -
EV / Revenue - - - 62.8 x -
EV / EBITDA - -31.9 x -23.4 x -35.9 x -37.3 x
EV / FCF - -29.7 x -21.3 x -27.9 x -25.2 x
FCF Yield - -3.36% -4.69% -3.58% -3.96%
Price to Book - 10.2 x 16.5 x 48.4 x -43.1 x
Nbr of stocks (in thousands) 14,698 16,919 17,377 - -
Reference price 3 28,458 54,000 42,450 42,450 42,450
Announcement Date 23/03/23 15/02/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - - - 12 -
EBITDA 1 - -28.64 -31 -21 -21
EBIT 1 - -31.34 -32 -22 -22
Operating Margin - - - -183.33% -
Earnings before Tax (EBT) - - - - -
Net income 1 -19.9 -36.85 -38 -31 -34
Net margin - - - -258.33% -
EPS 2 -1,426 -2,401 -2,173 -1,754 -1,920
Free Cash Flow 3 - -30,700 -34,000 -27,000 -31,000
FCF margin - - - -225,000% -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 23/03/23 15/02/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - - - 16 45
Net Cash position 1 - 0.56 13 - -
Leverage (Debt/EBITDA) - - - -0.7619 x -2.143 x
Free Cash Flow 2 - -30,700 -34,000 -27,000 -31,000
ROE (net income / shareholders' equity) - -63.9% -61.1% -104% -
ROA (Net income/ Total Assets) - -46.5% -42.1% -35.3% -37.3%
Assets 1 - 79.3 90.26 87.82 91.15
Book Value Per Share 3 - 5,301 2,569 877.0 -985.0
Cash Flow per Share - - - - -
Capex 1 - - - - -
Capex / Sales - - - - -
Announcement Date 23/03/23 15/02/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
42,450 KRW
Average target price
80,000 KRW
Spread / Average Target
+88.46%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A310210 Stock
  4. Financials Voronoi, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW